These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
62 related items for PubMed ID: 2142275
1. [Sensitivity curves of multiply resistant corynebacteria JK and D2]. Rauturier M, Darbas H, Jean-Pierre H, Boyer G, Rivière M. Pathol Biol (Paris); 1990 May; 38(5):420-5. PubMed ID: 2142275 [Abstract] [Full Text] [Related]
2. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters. Simon VC, Simon M. Scand J Infect Dis Suppl; 1990 May; 72():14-9. PubMed ID: 2151061 [Abstract] [Full Text] [Related]
3. Comparison of serum bactericidal activities of three experimental antibiotic regimens against Corynebacterium group JK. Chantrenne ML, De Knop RJ, Van Caekenberghe DL, Wouters RM. Chemioterapia; 1987 Jun; 6(2 Suppl):23-5. PubMed ID: 3509393 [No Abstract] [Full Text] [Related]
11. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci. Ravizzola G, Pirali F, Foresti I, Turano A. Drugs Exp Clin Res; 1987 Dec; 13(4):225-9. PubMed ID: 2957187 [Abstract] [Full Text] [Related]
12. Synergistic activity between vancomycin or teicoplanin and gentamicin or tobramycin against pathogenic diphtheroids. Spitzer PG, Eliopoulos GM, Karchmer AW, Moellering RC. Antimicrob Agents Chemother; 1988 Apr; 32(4):434-7. PubMed ID: 2967670 [Abstract] [Full Text] [Related]
13. [Antibiotic-resistant Corynebacteria--a new problem of infection in immunosuppressed patients]. Osterwalder B, Frei R, Gratwohl A, Reber H, Speck B. Schweiz Med Wochenschr; 1986 Jun 28; 116(26):880-4. PubMed ID: 3738458 [Abstract] [Full Text] [Related]
14. In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin. Machka K, Milatovic D, Braveny I. Chemioterapia; 1987 Jun 28; 6(2 Suppl):117-8. PubMed ID: 2978385 [No Abstract] [Full Text] [Related]
15. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Pankey G, Ashcraft D, Patel N. Antimicrob Agents Chemother; 2005 Dec 28; 49(12):5166-8. PubMed ID: 16304195 [Abstract] [Full Text] [Related]
17. [Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination]. Drugeon HB, Dellamonica P, Caillon J. Pathol Biol (Paris); 1987 May 28; 35(5):495-500. PubMed ID: 3302851 [Abstract] [Full Text] [Related]
18. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities. Babalola CP, Patel KB, Nightingale CH, Nicolau DP. Int J Antimicrob Agents; 2004 Apr 28; 23(4):343-8. PubMed ID: 15081082 [Abstract] [Full Text] [Related]
19. Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility. Mascellino MT, Iona E, Ponzo R, Mastroianni CM, Delia S. Int J Clin Pharmacol Res; 1994 Apr 28; 14(5-6):157-63. PubMed ID: 7672872 [Abstract] [Full Text] [Related]
20. In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198). O'Hare MD, Felmingham D, Grüneberg RN. J Chemother; 1989 Jul 28; 1(4 Suppl):210-1. PubMed ID: 16312373 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]